TUCSON, Ariz., Dec. 8, 2011 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com ), the privately-held manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been selected by Forbes as one of " America's Most Promising Companies ." The list features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers , strategic partners and precious investment capital. Ranked No. 77, SynCardia was the only Arizona company to make the cut.
(Photo: http://photos.prnewswire.com/prnh/20111208/LA19196 )
"In 2010, SynCardia doubled sales over 2009, and in 2011, we are on track to double sales again, representing a four-fold increase since 2009. We are profitable for the first time in the company's 10-year history," said Michael Garippa , CEO/President. "SynCardia is lean by design and many of our employees are cross-trained in multiple departments. Every Friday, we continue our six-year tradition of the entire company having lunch together and sharing project updates to ensure everyone is on the same page."
SynCardia designed, developed, and launched the Freedom® portable driver , the world's first wearable power supply for the SynCardia temporary Total Artificial Heart. Weighing 13.5 pounds, the Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. To date, 34 patients have been enrolled in the stu